| A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium–Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study I Frent, D Leucuta, C Bucsa, A Farcas, F Casoinic, C Mogosan Frontiers in Pharmacology 13, 925805, 2022 | 2 | 2022 |
| A Description of Medicines Associated Safety Issues Evaluated Through a Referral Procedure at the EU Level A Farcas, T Balcescu, C Mogosan DRUG SAFETY 41 (11), 1137-1137, 2018 | | 2018 |
| A description of medicines-related safety issues evaluated through a referral procedure at the EU level after 2012 A Farcas, T Balcescu, L Anghel, C Bucsa, C Mogoșan Expert opinion on drug safety 19 (6), 755-762, 2020 | 10 | 2020 |
| A Nationwide Study in Romania on the Use of Proton Pump Inhibitors Between 2012 and 2018 A Farcas, A Rusu, C Mogosan, C Bucsa Drug Safety 44 (12), 1439-1440, 2021 | | 2021 |
| A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders M Huruba, A Farcas, DC Leucuta, C Bucsa, M Sipos, C Mogosan Scientific Reports 11 (1), 14375, 2021 | 7 | 2021 |
| A VigiBase descriptive study of fluoroquinolone-associated peripheral nervous system disorders M Huruba, A Farcas, DC Leucuta, C Bucsa, C Mogosan Pharmaceuticals 15 (2), 143, 2022 | 8 | 2022 |
| Active Monitoring System To Identify and Characterize Adverse Drug Reactions in Hospitalized Patients in Romania AM Farcas, A Sinpetrean, CD Farah, DL Dumitrasu, AC Achimas, ... BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 109, 80-80, 2011 | | 2011 |
| Acute Renal Failure, Consequence of Perindopril and Ketoprofen Therapy C Bucsa, I Cazacu, A Farcas, A Achimas, M Bojita BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 109, 79-79, 2011 | 1 | 2011 |
| Acute Renal Failure, Consequence of Perindopril and Ketoprofen Therapy: A Case Report CD Bucsa, I Cazacu, AM Farcas, A Achimas, M Bojita DRUG SAFETY 34 (10), 994-994, 2011 | 1 | 2011 |
| Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania A Farcas, A Sinpetrean, C Mogosan, M Palage, O Vostinaru, M Bojita, ... European Journal of Internal Medicine 21 (5), 453-457, 2010 | 62 | 2010 |
| Adverse drug reactions in clinical practice: a causality assessment of a case of drug-induced pancreatitis A Farcas, M Bojita J Gastrointestin Liver Dis 18 (3), 353-358, 2009 | 63 | 2009 |
| Adverse drug reactions of analgesics spontaneously reported I Cazacu, G Miremont-Salame, H Geniaux, A Benard-Laribiere, A Daveluy, ... FUNDAMENTAL & CLINICAL PHARMACOLOGY 27, 93-94, 2013 | | 2013 |
| Adverse events following measles-mumps-rubella vaccination. A prospective observational study C Bucsa, N Bulik, A Farcas, S Muresan, I Muresan, O Oniga Farmacia 68 (2), 219-224, 2020 | 2 | 2020 |
| ADVERSE EVENTS FOLLOWING MEASLES-MUMPS-RUBELLA VACCINATION. A PROSPECTIVE OBSERVATIONAL STUDY C BUCȘA, N BULIK, A FARCAȘ, S MUREȘAN, I MUREȘAN, O ONIGA Farmacia 68 (2), 2020 | 1 | 2020 |
| Alternative therapies in gastric hypersecretion IM MATRAN¹, A FARCAŞ, M BOJIȚĂ, D DUMITRAŞCU | 4 | 2017 |
| Ampicillin induced cutaneous vasculitis: a case report C Mogosan, O Vostinaru, M Palage, AM Farcas, L Ciumarnean, ... FUNDAMENTAL & CLINICAL PHARMACOLOGY 24, 90-91, 2010 | | 2010 |
| An insight into statin use and its association with muscular side effects in clinical practice A Farcas, C Bucsa, D Leucuta, C Mogosan, M Bojita, D Dumitrascu Romanian Journal of Internal Medicine 53 (2), 153-160, 2015 | 5 | 2015 |
| An investigation of the concomitant use of angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs and diuretics. C Bucsa, DC Moga, A Farcas, C Mogosan, DL Dumitrascu European Review for Medical & Pharmacological Sciences 19 (15), 2015 | 6 | 2015 |
| An investigation on the association between sodium glucose co‐transporter 2 inhibitors use and acute pancreatitis: a VigiBase study I Frent, C Bucsa, D Leucuta, A Farcas, C Mogosan Pharmacoepidemiology and Drug Safety 30 (10), 1428-1440, 2021 | 10 | 2021 |
| An overview of the common methods used to measure treatment adherence LA Anghel, AM Farcas, RN Oprean Medicine and pharmacy reports 92 (2), 117, 2019 | 293 | 2019 |
